Cargando…

Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma

BACKGROUND: Epithelial-mesenchymal transition (EMT) is critical for cancer cell metastasis. Recently, EMT was reported to be associated with the inflammatory tumour microenvironment and, therefore, might be a predictive biomarker for immune checkpoint blockade agents. However, the underlying mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hong, Zhang, Yi, Zhou, Zhiwei, Guo, Yu, Huang, Xiaohui, Westover, Kenneth D., Zhang, Zhaohui, Chen, Bin, Hua, Yunpeng, Li, Shaoqiang, Xu, Ruiyun, Lin, Nan, Peng, Baogang, Shen, Shunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710851/
https://www.ncbi.nlm.nih.gov/pubmed/31324602
http://dx.doi.org/10.1016/j.ebiom.2019.07.002
_version_ 1783446422651142144
author Peng, Hong
Zhang, Yi
Zhou, Zhiwei
Guo, Yu
Huang, Xiaohui
Westover, Kenneth D.
Zhang, Zhaohui
Chen, Bin
Hua, Yunpeng
Li, Shaoqiang
Xu, Ruiyun
Lin, Nan
Peng, Baogang
Shen, Shunli
author_facet Peng, Hong
Zhang, Yi
Zhou, Zhiwei
Guo, Yu
Huang, Xiaohui
Westover, Kenneth D.
Zhang, Zhaohui
Chen, Bin
Hua, Yunpeng
Li, Shaoqiang
Xu, Ruiyun
Lin, Nan
Peng, Baogang
Shen, Shunli
author_sort Peng, Hong
collection PubMed
description BACKGROUND: Epithelial-mesenchymal transition (EMT) is critical for cancer cell metastasis. Recently, EMT was reported to be associated with the inflammatory tumour microenvironment and, therefore, might be a predictive biomarker for immune checkpoint blockade agents. However, the underlying mechanism is still unclear. METHODS: Patient survival data for our HCC cohort, TCGA and GEO datasets were determined by Kaplan-Meier analysis. The functional roles of ELMO1 in HCC were demonstrated by a series of in vitro and in vivo experiments. Gene microarray analysis was used to demonstrate potential mechanisms of ELMO1. Data retrieved from the TCGA datasets were used to determine the relationships of ELMO1, EMT and TMB. FINDINGS: Here, we report an indispensable role for ELMO1 in linking EMT with tumour mutation burden (TMB), which is a promising biomarker for the immune checkpoint blockade agent response. Upregulated ELMO1 expression is associated with a poor prognosis in hepatocellular carcinoma (HCC), as well as increased cell growth, invasion, migration, angiogenesis and EMT in vitro and in vivo. Mechanistically, we provide evidence that ELMO1 regulates SOX10 expression and induces EMT through PI3K/Akt signalling. Moreover, ELMO1 is negatively associated with TMB, indicating a negative relationship between EMT and TMB. INTERPRETATION: ELMO1 serves as a link between EMT and TMB, providing a mechanistic basis for the further development of ELMO1 as a therapeutic target against HCC and potentially a promising biomarker of the immune checkpoint blockade agent response. FUND: National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province; Young Teacher Training Program of Sun Yat-sen University; Science and Technology Plan of Guangdong Province; Special Support Program of Guangdong Province, Science and Technology Innovation Youth Talent Support Program; the Pearl River Science and Technology New Talent of Guangzhou City; Medical Scientific Research Foundation of Guangdong Province.
format Online
Article
Text
id pubmed-6710851
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67108512019-08-29 Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma Peng, Hong Zhang, Yi Zhou, Zhiwei Guo, Yu Huang, Xiaohui Westover, Kenneth D. Zhang, Zhaohui Chen, Bin Hua, Yunpeng Li, Shaoqiang Xu, Ruiyun Lin, Nan Peng, Baogang Shen, Shunli EBioMedicine Research paper BACKGROUND: Epithelial-mesenchymal transition (EMT) is critical for cancer cell metastasis. Recently, EMT was reported to be associated with the inflammatory tumour microenvironment and, therefore, might be a predictive biomarker for immune checkpoint blockade agents. However, the underlying mechanism is still unclear. METHODS: Patient survival data for our HCC cohort, TCGA and GEO datasets were determined by Kaplan-Meier analysis. The functional roles of ELMO1 in HCC were demonstrated by a series of in vitro and in vivo experiments. Gene microarray analysis was used to demonstrate potential mechanisms of ELMO1. Data retrieved from the TCGA datasets were used to determine the relationships of ELMO1, EMT and TMB. FINDINGS: Here, we report an indispensable role for ELMO1 in linking EMT with tumour mutation burden (TMB), which is a promising biomarker for the immune checkpoint blockade agent response. Upregulated ELMO1 expression is associated with a poor prognosis in hepatocellular carcinoma (HCC), as well as increased cell growth, invasion, migration, angiogenesis and EMT in vitro and in vivo. Mechanistically, we provide evidence that ELMO1 regulates SOX10 expression and induces EMT through PI3K/Akt signalling. Moreover, ELMO1 is negatively associated with TMB, indicating a negative relationship between EMT and TMB. INTERPRETATION: ELMO1 serves as a link between EMT and TMB, providing a mechanistic basis for the further development of ELMO1 as a therapeutic target against HCC and potentially a promising biomarker of the immune checkpoint blockade agent response. FUND: National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province; Young Teacher Training Program of Sun Yat-sen University; Science and Technology Plan of Guangdong Province; Special Support Program of Guangdong Province, Science and Technology Innovation Youth Talent Support Program; the Pearl River Science and Technology New Talent of Guangzhou City; Medical Scientific Research Foundation of Guangdong Province. Elsevier 2019-07-16 /pmc/articles/PMC6710851/ /pubmed/31324602 http://dx.doi.org/10.1016/j.ebiom.2019.07.002 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research paper
Peng, Hong
Zhang, Yi
Zhou, Zhiwei
Guo, Yu
Huang, Xiaohui
Westover, Kenneth D.
Zhang, Zhaohui
Chen, Bin
Hua, Yunpeng
Li, Shaoqiang
Xu, Ruiyun
Lin, Nan
Peng, Baogang
Shen, Shunli
Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
title Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
title_full Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
title_fullStr Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
title_full_unstemmed Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
title_short Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
title_sort intergrated analysis of elmo1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
topic Research paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710851/
https://www.ncbi.nlm.nih.gov/pubmed/31324602
http://dx.doi.org/10.1016/j.ebiom.2019.07.002
work_keys_str_mv AT penghong intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT zhangyi intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT zhouzhiwei intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT guoyu intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT huangxiaohui intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT westoverkennethd intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT zhangzhaohui intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT chenbin intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT huayunpeng intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT lishaoqiang intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT xuruiyun intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT linnan intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT pengbaogang intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma
AT shenshunli intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma